Astel­las pur­sues ‘con­vert­ible’ in vi­vo CAR-T cell ther­a­pies with Kelo­nia Ther­a­peu­tics

Astel­las is pen­ning a deal with Kelo­nia Ther­a­peu­tics to de­vel­op in vi­vo cell ther­a­pies to treat can­cer, but with a twist.

Not on­ly would the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA